KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardlytics (CDLX) Net Margin (2017 - 2026)

Cardlytics filings provide 10 years of Net Margin readings, the most recent being 27.15% for Q1 2026.

  • Quarterly Net Margin rose 3240.0% to 27.15% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 39.32% through Mar 2026, up 2356.0% year-over-year, with the annual reading at 44.36% for FY2025, 2366.0% up from the prior year.
  • Net Margin hit 27.15% in Q1 2026 for Cardlytics, up from 14.71% in the prior quarter.
  • Across five years, Net Margin topped out at 48.64% in Q1 2022 and bottomed at 458.5% in Q4 2022.
  • Average Net Margin over 5 years is 67.55%, with a median of 21.07% recorded in 2024.
  • The largest annual shift saw Net Margin tumbled -44536bps in 2022 before it skyrocketed 34542bps in 2023.
  • Cardlytics' Net Margin stood at 458.5% in 2022, then soared by 75bps to 113.09% in 2023, then surged by 81bps to 21.07% in 2024, then skyrocketed by 30bps to 14.71% in 2025, then skyrocketed by 285bps to 27.15% in 2026.
  • Per Business Quant, the three most recent readings for CDLX's Net Margin are 27.15% (Q1 2026), 14.71% (Q4 2025), and 139.67% (Q3 2025).